Peter Imming
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications 12
- Synthesis and biological activity 9
- Synthesis and Biological Evaluation 7
- Pharmacology top 2%
- Molecular Biology top 10%
- Phenothiazines and Benzothiazines Synthesis and Activities 13
- Cancer therapeutics and mechanisms 9
- Chemical Synthesis and Analysis 9
- Pharmacology top 5%
-
- Tuberculosis Research and Epidemiology 9
-
- Mycobacterium research and diagnosis 7
- Co-authors
- Achim MeyerG. SEITZLea Ann DaileyBernhard WatzerVincenzo Di MarzoAron H. LichtmanJoel E. SchlosburgRüdiger W. Seidel
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Peter Imming
105 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Organic Chemistry 549
- Pharmacology 167
- Computational Theory and Mathematics 237
- Molecular Biology 929
- Pharmacology 224
Countries citing papers authored by Peter Imming
This map shows the geographic impact of Peter Imming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Imming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Imming more than expected).
Fields of papers citing papers by Peter Imming
This network shows the impact of papers produced by Peter Imming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Imming. The network helps show where Peter Imming may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Imming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 7 | |
| 14 | 2018 | 45 | |
| 15 | 2017 | 7 | |
| 16 | 2017 | 29 | |
| 17 | 2015 | 24 | |
| 18 | 2011 | 96 | |
| 19 | 2010 | 3 | |
| 20 | 2001 | 6 |
About Peter Imming
Peter Imming is a scholar working on Organic Chemistry, Biophysics and Pharmacology, having authored 111 papers that have together received 2.0k indexed citations. Recurring topics across this work include Phenothiazines and Benzothiazines Synthesis and Activities (13 papers), Quinazolinone synthesis and applications (12 papers), Synthesis and biological activity (9 papers), Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (9 papers), Chemical Synthesis and Analysis (9 papers), Synthesis and Biological Evaluation (7 papers) and Mycobacterium research and diagnosis (7 papers). The work is most often cited by research in Organic Chemistry (549 citations), Pharmacology (167 citations) and Computational Theory and Mathematics (237 citations). Peter Imming has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Achim Meyer, G. SEITZ, Lea Ann Dailey, Bernhard Watzer, Vincenzo Di Marzo, Aron H. Lichtman, Joel E. Schlosburg, Rüdiger W. Seidel, Rolf M. Nüsing and Maria Grazia Cascio. Their work appears in journals such as Archiv der Pharmazie, Planta Medica, Molecules, Journal of Medicinal Chemistry and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.